Godavari Drugs has informed that the trading window for dealing in the Company's securities by its Designated persons and their Immediate Relatives will remain closed from Wednesday, April 01, 2026 till 48 hours after the declaration of the Audited Financial Results for the quarter and financial year ending March 31, 2026. Further, the date of the Board Meeting for consideration and approval of Audited Financial Results of the Company for the quarter and financial year ending March 31, 2026 shall be intimated to the Stock Exchange in due course of time.
The above information is a part of company’s filings submitted to BSE.
